-
Johanna FIHMAN started a new discussion, WHO Vaccine Evidence Compendium🌍 Introducing the WHO Vaccine Evidence Compendium
A new one-stop resource to support countries in collecting and accessing reliable evidence for faster, evidence-based decisions on vaccine introduction, prioritization and portfolio optimization.
🔎 What is it?
The WHO Vaccine Evidence Compendium is a centralized, curated platform hosted on the NITAG Resource Centre, designed to streamline access to reliable and up to date immunization evidence for national decision-makers.
🎯 Objectives
- Enhance countries’ ability to make strategic, data-informed decisions on vaccine introduction, prioritization and optimization by improving access to reliable, up-to-date evidence
- Alleviate the workload of evidence gathering for NITAGs and EPI managers
📦 What does it include?
- Evidence packages for 4 pilot vaccines: Hexavalent, HPV, RSV, and PCV
- Standardized indicators and curated data aligned with existing tools ( including Evidence to Recommendation, New Vaccine Introduction...
More🌍 Introducing the WHO Vaccine Evidence Compendium
A new one-stop resource to support countries in collecting and accessing reliable evidence for faster, evidence-based decisions on vaccine introduction, prioritization and portfolio optimization.
🔎 What is it?
The WHO Vaccine Evidence Compendium is a centralized, curated platform hosted on the NITAG Resource Centre, designed to streamline access to reliable and up to date immunization evidence for national decision-makers.
🎯 Objectives
- Enhance countries’ ability to make strategic, data-informed decisions on vaccine introduction, prioritization and optimization by improving access to reliable, up-to-date evidence
- Alleviate the workload of evidence gathering for NITAGs and EPI managers
📦 What does it include?
- Evidence packages for 4 pilot vaccines: Hexavalent, HPV, RSV, and PCV
- Standardized indicators and curated data aligned with existing tools ( including Evidence to Recommendation, New Vaccine Introduction Prioritization and Sequencing tool).
- Exportable content for use in workshops, presentations, and policy briefs, including tables comparing vaccine products.
🔮 What’s coming next?
- Ongoing updates aligned with SAGE reviews and country feedback.
- Expansion to additional vaccines in 2026.
🤝 Country driven, co-created with countries
- Developed through consultations with NITAGs, regional workshops, and global partners to ensure relevance for country users
- Guided by a Steering Committee of immunization experts to ensure quality, consistency and long-term utility
📣 How to access and share
- Available at : www.nitag-resource.org/compendium
- Share with NITAGs, WHO/UNICEF country offices, EPI managers, and partners.
Post is under moderationStream item published successfully. Item will now be visible on your stream.
Johanna FIHMAN is now following Po RinPost is under moderationStream item published successfully. Item will now be visible on your stream.
Johanna FIHMAN is now following Shashi Kant RayPost is under moderationStream item published successfully. Item will now be visible on your stream.
Johanna FIHMAN is now following Lokesh AlahariPost is under moderationStream item published successfully. Item will now be visible on your stream.
Johanna FIHMAN started a new discussion, Take a look at IA2030 In depth review - MICs!In the last 50 years alone, vaccines have saved 154 million lives. That’s 6 people every minute, for five decades. But there are still millions of children who receive zero doses of vaccines - 1 in 3 of these children currently live in middle-income countries. What should be done to ensure these children get the vaccines they need? And to ensure no child is left behind.
Today IA2030 has launched an in-depth review on increasing immunization in middle-income countries that highlights four key actions needed:
1 – Middle-income countries need to sustain or increase financing of vaccines depending on context: vaccines need to be considered part of the package of essential health services.
2 – Vaccines can cost 10x more in middle-income countries than GAVI eligible countries: vaccines suppliers must ensure improved availability and affordability of vaccines for middle-income countries, and countries should consider procuring vaccines from diverse manufacturing bases.
3 – Often due to...Post is under moderationStream item published successfully. Item will now be visible on your stream.Dyuti Schuwey-Daeppen reacted to this post about 2 years ago
Johanna FIHMAN started a new discussion, WHO TAG Market Access for Vaccines (TAG MVAC) - call for applicationThe WHO Technical Advisory Group on Market Access for Vaccines (TAG MVAC) supports WHO’s work related to global vaccine market topics including delivering recommendations on our global market studies under the Market Information for Access (MI4A) work.
WHO is seeking for experienced and highly qualified experts to serve as members of the TAG MVAC for a two-year appointment with following expertise:
- Global vaccine supply, demand, and market landscape dynamics across key regions and immunization areas;
- Vaccine manufacturing;
- Global immunization and/or infectious disease epidemiology;
- Global vaccine market access and/or procurement
The call for application is currently open, the deadline for submitting the application is 14 June 2024.
For any question please contact [email protected]
Thank you
...Post is under moderationStream item published successfully. Item will now be visible on your stream.Shashi Kant Ray reacted to this post about 2 years ago
Johanna FIHMAN started a new discussion, New Webinar: Introduction to the National Immunization Strategy (NIS)Updated guidance to support countries in the development of National Immunization Strategies (NIS) is now available in English, French and Russian at https://www.who.int/teams/immunization-vaccines-and-biologicals/vaccine-access/planning-and-financing/nis. The Guidance is accompanied by a new and simplified costing approach to support the NIS process, NIS.COST https://immunizationeconomics.org/unicef-niscost, as well as guidance on Annual Operational Planning (AOPs).
The new NIS guidance focuses on more informed, country owned, and sustainable decision-making and the prioritization of interventions needed to reach zero dose children and communities in line with Immunization Agenda 2030. It also supports a dialogue between Ministry of Health and Finance leads to ensure an agreed financial envelope is available to fund NIS key strategic priorities. In addition, there is greater emphasis on a broad and inclusive dialogue at the country level and greater integration with the health care...Post is under moderationStream item published successfully. Item will now be visible on your stream.
Johanna FIHMAN added a new resource to the Knowledge HubGlobal Market Study: Meningococcal meningitis vaccines - 2019
The WHO initiative, Market Information for Access to Vaccines (MI4A) produces vaccine-specific market studies, analyzing global demand and supply prospects for individual vaccines. The studies identify areas of risk for sustainable access to vaccine supply and define mitigating actions. The market studies are updated regularly. This publication is the first on Meningococcal Meningitis vaccines.
...Post is under moderationStream item published successfully. Item will now be visible on your stream.
Johanna FIHMAN added a new resource to the Knowledge HubNational Immunization Strategies (NIS): Resources in English
This page provides all the latest guidance and support documents for the development of a National Immunization Strategy (NVS) available in English. The page will be updated regularly. Please contact [email protected] for any questions.
IA2030
{khub-list,reference,EN-IA-2030,title ASC, 50}
National Immunization Strategy (NIS)
{khub-list,reference,EN-NIS,title ASC, 50}
NIS Training Tools
{khub-list,reference,EN-NIS-TRAINING,title ASC, 50}
NIS Additional Resources
{khub-list,reference,EN-NIS-RESOURCES,title ASC, 50}
Pretoria 2022: workshop preparation
{khub-list,reference,SA-WORKSHOP,title ASC, 50}
...Post is under moderationStream item published successfully. Item will now be visible on your stream.Stream item published successfully. Item will now be visible on your stream.Stream item published successfully. Item will now be visible on your stream.There are no activities here yet
Pinned Items
Recent Activities